Webinar on “Latest advances in the treatment of acute lymphoblastic leukemia (ALL) – What does this mean for patients?” held on 28 March 2023

On 30 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted fourth webinar in the series.

This webinar brought together international patients with ALL, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how ALL is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22. What is new and what does this mean for patients?

Click here to access the description and the recording

Webinar on “Latest advances in the treatment of chronic myeloid leukemia (CML) – What does this mean for patients?” held on 28 March 2023

On 28 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted third webinar in the series of four.

This webinar brought together international patients with CML, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how CML is treated today. Current approved therapies and their place in the treatment algorithm and management approaches long term. What  were the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22? What does this mean for patients?

Click here to access the description and the recording

Webinar on “Latest advances in the treatment of chronic lymphocytic leukemia (CLL) – What does this mean for patients?” held on 27 March 2023

On 27 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted second webinar in the series of four.

This webinar brought together international patients with CLL, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how CLL is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22. What is new and what does this mean for patients?

Click here to access the description and the recording

Webinar on “Latest advances in the treatment of acute myeloid leukemia (AML) – What does this mean for patients?” held on 21 March 2023

On 21 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted the first webinar in the series of four.

This webinar brought together international patients with AML, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how AML is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22. What is new and what does this mean for patients?

Click here to access the description and the recording

Webinar – “How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?” held on 7 December 2022

This educational webinar explained in simple language to a layperson audience the basic science behind BTK targeted therapies in use or study today to treat CLL. How they work, how they are used and latest developments.

This webinar was organised by CLL Advocates Network.

Click here to access the description and the recording

Webinar on “CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs” held on 6 December 2022

This educational session discussed advances in how relapsed/refractory CLL patients and those who fail a treatment are treated today. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs?

This webinar was organised by CLL Advocates Network.

Click here to access the description and the recording

Webinar on “Latest updates on CLL and what this means for you” held on 10 February 2022

This webinar was aimed at patients and advocates to provide an overview of latest developments in the treatment of CLL that were presented at The American Society of Haematology (ASH) Conference in Georgia, US, December 2021

We were joined by Dr Piers Patten – Consultant Haematologist and Senior Lecturer, Kings College Hospital NHS Foundation Trust

This webinar was organised as a collaboration between the CLL Advocates Network and Leukaemia Care.

Click here to access the description and the recording

Webinar on “How to sustainably build and develop a patient group” held on 30 June 2021

Click here to access the description, the slide deck and the recording

Webinar on “COVID-19 vaccination and immune challenges for leukemia” held on 11 February 2021

Click here to access the description, full slide deck and the recording

Webinar on “Developing collaboration between patient groups and clinical groups – working together to improve patient outcomes” held on 30 September 2020

Click here to access the description and recording